AI Tool Detects Early Signs of Over 1,000 Diseases, Researchers Reveal

Sponsored Ad

A groundbreaking AI technology named MILTON can detect the early signs of over 1,000 diseases, long before symptoms appear, according to new research. Developed by pharmaceutical giant AstraZeneca, this tool analyzes routine patient test data to predict future diseases with high accuracy, potentially revolutionizing medical diagnostics.

Using data from the UK Biobank, MILTON examines biomarkers like blood pressure and protein levels to identify subtle patterns linked to diseases such as Alzheimer’s and kidney disease. Researchers hope this will lead to earlier intervention and more personalized treatments.

Despite the tool’s promise, experts emphasize the need for ethical safeguards to prevent misuse by insurers or employers. MILTON is currently a research tool, with more work required before clinical use.